PL EN
 
PL EN
Current issue
Online first
Archive
About the Journal
For Authors

Topic Pharmacotherapy and Pharmacology

 

Metabolic syndrome in patients who have been subjected to isolation security measures and treated with atypical antipsychotics
Przemysław Cynkier, Inga Markiewicz, Grzegorz Kudlak, Dorota Antoniak, Janusz Heitzman
Psychiatr Pol 2024;58(5):845-862
DOI: https://doi.org/10.12740/PP/OnlineFirst/163553
 

Depression and ineffective reproduction, i.e. psychiatric aspects of infertility
Damian Zieliński, Kamila Tokarczyk, Magdalena Piegza
DOI: https://doi.org/10.12740/PP/OnlineFirst/191103
 

Dopamine D2 receptor partial agonists in the treatment of schizophrenia -example of brexpiprazole
Katarzyna Maria Bliźniewska-Kowalska, Piotr Gałecki
Psychiatr Pol 2024;58(4):581-593
DOI: https://doi.org/10.12740/PP/174593
 

Use of the opioid receptor antagonist – naltrexone in the treatment of non-suicidal self-injury
Hanna Karakuła-Juchnowicz, Agnieszka Banaszek, Dariusz Juchnowicz
Psychiatr Pol 2024;58(4):605-618
DOI: https://doi.org/10.12740/PP/OnlineFirst/161954
 

Prevalence and determinants of psychotropic medication use in Poland
Agnieszka Pisarska, Jakub Stokwiszewski, Jacek Moskalewicz
Psychiatr Pol 2024;58(4):619-636
DOI: https://doi.org/10.12740/PP/OnlineFirst/159734
 

Efficacy and safety of aripiprazole in the treatment of delirium.
Marcin Jarosz, Karina Aagnieszka Badura Brzoza
Psychiatr Pol 2024;58(4):595-604
DOI: https://doi.org/10.12740/PP/OnlineFirst/156262
 

Polish standard of treatment with racemic ketamine for patients with depressive disorders developed by a Working Group appointed by the National Consultant in the field of psychiatry
Piotr Gałecki, Katarzyna Maria Bliźniewska-Kowalska, Wiesław Jerzy Cubała, Anna Depukat, Anna Mosiołek, Janusz Rybakowski, Jerzy Samochowiec, Bogusław Sobolewski, Agata Szulc, Dominika Dudek
Psychiatr Pol 2024;58(3):377-401
DOI: https://doi.org/10.12740/PP/189494
 

Clinical experience with parenteral trazodone in mood disorders: A literature review
Calogero Crapanzano, Ilaria Casolaro, Anna Julia Krupa
Psychiatr Pol 2024;58(3):449-466
DOI: https://doi.org/10.12740/PP/182933
 

Management of nicotine dependence in patients with psychiatric disorders – recommendations of the Polish Psychiatric Association – part II
Marcin Wojnar, Piotr Wierzbiński, Jerzy Samochowiec, Joanna Rymaszewska, Krzysztof J. Filipiak, Adam Wichniak, Robert Mróz, Artur Mamcarz, Dominika Dudek
Psychiatr Pol 2024;58(3):419-431
DOI: https://doi.org/10.12740/PP/OnlineFirst/161774
 

Management of nicotine dependence in patients with psychiatric disorders – recommendations of the Polish Psychiatric Association – part I
Marcin Wojnar, Piotr Wierzbiński, Jerzy Samochowiec, Joanna Rymaszewska, Krzysztof J. Filipiak, Adam Wichniak, Robert Mróz, Artur Mamcarz, Dominika Dudek
Psychiatr Pol 2024;58(3):403-418
DOI: https://doi.org/10.12740/PP/OnlineFirst/161773
 

Sixty years of recurrence prevention in mood disorders
Janusz Rybakowski
Psychiatr Pol 2024;58(2):223-236
DOI: https://doi.org/10.12740/PP/169407
 

First onset of persistent neutropenia in patient undergoing long-term clozapine treatment after vaccination against COVID-19 and SARS-CoV-2 infection in short interval – a case report
Alicja Kawalec, Lena Cichoń, Krzysztof Wilczyński, Małgorzata Janas-Kozik
DOI: https://doi.org/10.12740/PP/OnlineFirst/174064
 

Paroxysmal rush of intrusive eidetic images – diagnostic doubts. Case report
Krzysztof Świerzy, Dominika Tatar, Aleksandra Leksowska, Karina Badura-Brzoza
Psychiatr Pol 2024;58(1):201-212
DOI: https://doi.org/10.12740/PP/159446
 

Around anesthesia: anesthetic aspects of electroconvulsive treatment in the light of the latest reports – review article
Patryk Rodek, Wojciech Mędrala, Jan Chrobak, Aleksandra Barabasz-Gembczyk, Barbara Alli-Balogun, Krzysztof Kucia
DOI: https://doi.org/10.12740/PP/OnlineFirst/174768
 

Psychopathological symptoms in fibromyalgia and their associations with resistance to pharmacotherapy with SNRI
Anna Julia Krupa, Adrian Andrzej Chrobak, Zbigniew Sołtys, Mariusz Korkosz, Jaroslaw Nowakowski, Dominika Dudek, Marcin Siwek
DOI: https://doi.org/10.12740/PP/OnlineFirst/176000
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2023;57(6):1105-1106
DOI: https://doi.org/10.12740/PP/183125
 

Patient with Asperger's Syndrome, with episodes of fantasizing and rocking of body, treated with aripiprazole - a case report.
Maciej Dul, Krzysztof Walczewski
Psychiatr Pol 2023;57(6):1135-1142
DOI: https://doi.org/10.12740/PP/152316
 

A rare case of fatal poisoning during long-term therapy with lithium carbonate - chronic poisoning, suicide or psychiatric malpractice?
Rafał Skowronek, Anna Skowronek, Sylwia Tarka, Zofia I. Niemir, Jerzy Chudek, Marek Krzystanek
Psychiatr Pol 2023;57(6):1127-1133
DOI: https://doi.org/10.12740/PP/OnlineFirst/152050
 

Vortioxetine – pharmacological properties and use in mood disorders. The current state of knowledge
Anna Julia Krupa, Krzysztof Wojtasik-Bakalarz, Marcin Siwek
Psychiatr Pol 2023;57(6):1109-1126
DOI: https://doi.org/10.12740/PP/OnlineFirst/151570
 

TED (Trazodone Effectiveness in Depression): effectiveness of trazodone extended-release in subjects with unsatisfactory response to SSRIs
Marcin Siwek, Adrian Andrzej Chrobak, Anna Julia Krupa, Aleksandra Gorostowicz, Adrian Gerlich, Andrzej Juryk, Dominika Dudek
DOI: https://doi.org/10.12740/PP/OnlineFirst/174432
 

The place of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents. Recommendations of the Main Board of the Polish Psychiatric Association. Part 2 – pharmacological properties and safety of use
Małgorzata Honorata Janas-Kozik, Agnieszka Słopień, Barbara Remberk, Marcin Siwek
Psychiatr Pol 2023;57(5):917-940
DOI: https://doi.org/10.12740/PP/171464
 

The risk of pulmonary embolism in the context of various clinical situations and management in psychiatric patients
Karolina Sapota-Zaręba, Tadeusz Nasierowski
Psychiatr Pol 2023;57(5):955-965
DOI: https://doi.org/10.12740/PP/152585
 

Catatonic syndrome during COVID-19 - a case study
Szymon Florek, Wojciech Sołtys, Marta Bielówka, Aleksandra Kołodziejska
Psychiatr Pol 2023;57(5):1001-1010
DOI: https://doi.org/10.12740/PP/OnlineFirst/149297
 

Persistent delusional disorder with delusions of poverty – a case study
Patryk Rodek, Krzysztof Kucia
Psychiatr Pol 2023;57(5):995-999
DOI: https://doi.org/10.12740/PP/OnlineFirst/143044
 

Letter to Editor. Position of the Polish Psychiatric Association on the use of benzodiazepine derivatives and drugs with a similar mechanism of action in the treatment of mental disorders
Adam Wichniak, Przemysław Bieńkowski, Dominika Dudek, Piotr Gałecki, Janusz Heitzman, Małgorzata Janas-Kozik, Maciej Matuszczyk, Michał Mielimąka, Sławomir Murawiec, Jerzy Samochowiec, Agata Szulc
Psychiatr Pol 2023;57(4):873-875
DOI: https://doi.org/10.12740/PP/169894
 

The position statement of the Working Group on the treatment of post-traumatic stress disorders in adults
Tytus Koweszko, Bogdan de Barbaro, Bernadetta Izydorczyk, Agnieszka Mastalerz-Migas, Jerzy Samochowiec, Agata Szulc, Adrianna Kowalska, Katarzyna Wachowska, Piotr Gałecki
Psychiatr Pol 2023;57(4):705-727
DOI: https://doi.org/10.12740/PP/166172
 

Treatment of insomnia in older adults. Recommendations of the Polish Sleep Research Society, Polish Society of Family Medicine and the Polish Psychiatric Association
Adam Wichniak, Przemysław Bieńkowski, Rafał Dąbrowski, Agnieszka Mastalerz-Migas, Joanna Rymaszewska
Psychiatr Pol 2023;57(3):495-516
DOI: https://doi.org/10.12740/PP/OnlineFirst/161597
 

Classical psychedelics in psychiatry – renaissance of interest and therapeutic perspectives
Askaniusz Jachimowski, Krzysztof Kucia
Psychiatr Pol 2023;57(3):657-670
DOI: https://doi.org/10.12740/PP/150053
 

Coexistence and clinical implications of anemia and depression in the elderly population
Sylwia Sulimiera Michalak, Władysław Sterna
Psychiatr Pol 2023;57(3):517-528
DOI: https://doi.org/10.12740/PP/147079
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2023;57(1):3-4
DOI: https://doi.org/10.12740/PP/162010
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2022;56(6):1149-1150
DOI: https://doi.org/10.12740/PP/159174
 

Principles of patients selection and safety of repetitive transcranial magnetic stimulation – position statement of the Section of Biological Psychiatry of the Polish Psychiatric Association
Jakub Maria Antczak, Weronika Dębowska, Anna Poleszczyk, Jakub Kaźmierski, Joanna Rymaszewska, Napoleon Waszkiewicz, Adam Wichniak
Psychiatr Pol 2022;56(6):1165-1184
DOI: https://doi.org/10.12740/PP/144110
 

Vitamin D deficiency and depressive symptoms: meta-analysis of studies .
Krzysztof Maria Wilczyński, Katarzyna Chęcińska, Krzysztof Kulczyk, Małgorzata Janas-Kozik
Psychiatr Pol 2022;56(6):1327-1344
DOI: https://doi.org/10.12740/PP/OnlineFirst/130992
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2022;56(5):927-928
DOI: https://doi.org/10.12740/PP/156192
 

Infections and mental diseases: from tuberculosis to COVID-19
Janusz Rybakowski
Psychiatr Pol 2022;56(5):931-944
DOI: https://doi.org/10.12740/PP/152125
 

Studies on candidate genes for lithium prophylaxis performed at the Poznan University of Medical Sciences
Ewa Ferensztajn-Rochowiak, Monika Dmitrzak-Węglarz, Aleksandra Szczepankiewicz, Maria Skibińska, Sebastian Kliwicki, Agnieszka Permoda-Pachuta, Aleksandra Suwalska, Piotr Czerski, Joanna Pawlak, Joanna Hauser
Psychiatr Pol 2022;56(5):1003-1016
DOI: https://doi.org/10.12740/PP/140889
 

Ketamine - a long way from anesthetic to a prototype antidepressant: Review of potential mechanisms of action
Bartłomiej Pochwat
Psychiatr Pol 2022;56(5):1017-1032
DOI: https://doi.org/10.12740/PP/OnlineFirst/134330
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2022;56(4):671-672
DOI: https://doi.org/10.12740/PP/154900
 

Experts and national consultants’ recommendations regarding management of patients treated for migraine with comorbid depression. Diagnosis. Therapeutic strategies. Part 2
Adam Stepień, Agnieszka Słowik, Izabela Domitrz, Wojciech Kozubski, Konrad Rejdak, Jacek Rożniecki, Jarosław Woroń, Katarzyna Wachowska, Piotr Gałecki
Psychiatr Pol 2022;56(4):711-728
DOI: https://doi.org/10.12740/PP/OnlineFirst/139596
 

Experts and national consultants’ recommendations regarding management of patients treated for migraine with comorbid depression. Epidemiology. Pathomechanism. Comorbidity. Part 1
Adam Stępień, Izabela Domitrz, Wojciech Kozubski, Konrad Rejdak, Jacek Rożniecki, Agnieszka Słowik, Jarosław Woroń, Katarzyna Wachowska, Piotr Gałecki
Psychiatr Pol 2022;56(4):697-710
DOI: https://doi.org/10.12740/PP/OnlineFirst/136489
 

Practice of prescribing antipsychotics in schizophrenia during 2013-2018 based on data from the National Health Fund
Marta Anczewska, Marek Balicki, Amelia Droździkowska, Piotr Gorczyca, Jolanta Janus, Sylwia Paciorek, Robert Plisko, Mariusz Zięba
Psychiatr Pol 2022;56(4):751-766
DOI: https://doi.org/10.12740/PP/OnlineFirst/134082
 

Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.
Sandra Szafoni, Gniewko Więckiewicz, Robert Pudlo, Piotr Gorczyca, Magdalena Piegza
Psychiatr Pol 2022;56(4):823-836
DOI: https://doi.org/10.12740/PP/OnlineFirst/133919
 

Pharmacotherapy of alcohol withdrawal syndromes – Recommendations of the Polish Psychiatric Association and the Pharmacotherapy Section of the Polish Society for Addiction Research
Paweł Mierzejewski, Przemysław Bieńkowski, Andrzej Jakubczyk, Jerzy Samochowiec, Andrzej Silczuk, Marcin Wojnar
Psychiatr Pol 2022;56(3):433-452
DOI: https://doi.org/10.12740/PP/OnlineFirst/149321
 

Use of psychotropic medications during lactation – practical guidelines for psychiatrists
Aleksandra Kamińska-Sobczak, Oliwia Gawlik-Kotelnicka, Dominik Strzelecki
Psychiatr Pol 2022;56(3):493-508
DOI: https://doi.org/10.12740/PP/134254
 

A naturalistic, 24-week, open-label, add-on study of vortioxetine in bipolar depression
Marcin Siwek, Adrian Andrzej Chrobak, Zbigniew Sołtys, Dominika Dudek, Anna Julia Krupa, Janusz Kazimierz Rybakowski
Psychiatr Pol 2022;56(3):509-522
DOI: https://doi.org/10.12740/PP/OnlineFirst/132962
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2022;56(2):201-202
DOI: https://doi.org/10.12740/PP/149406
 

Letter to Editor. Therapy with lithium as a protective factor against SARS-CoV-2 infection? Observations from the disease outbreak.
Aleksandra Gorostowicz, Dominika Dudek, Marcin Siwek
Psychiatr Pol 2022;56(2):417-422
DOI: https://doi.org/10.12740/PP/147109
 

Use of fentanyl, butyrfentanyl and furanylfentanyl as discussed on Polish online forums devoted to new psychoactive substances.
Monika Kacela, Jakub Wojcieszak, Jolanta Barbara Zawilska
Psychiatr Pol 2022;56(2):355-372
DOI: https://doi.org/10.12740/PP/OnlineFirst/128156
 

Glycine Transporters in Schizophrenia. A New Hope or Informational Noise?
Przemysław Zakowicz, Joanna Pawlak
Psychiatr Pol 2022;56(2):217-228
DOI: https://doi.org/10.12740/PP/OnlineFirst/126661
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2021;55(5):937-938
DOI: https://doi.org/10.12740/PP/143596
 
LETTER
 

A letter to the Editor. Documented persistent lack of cooperation during treatment of schizophrenia – recommendations of the National Consultant in Psychiatry
Piotr Gałecki
Psychiatr Pol 2021;55(5):1183-1185
DOI: https://doi.org/10.12740/PP/141640
 
ARTICLE
 

The position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in special populations
Adam Wichniak, Marcin Siwek, Joanna Rymaszewska, Małgorzata Janas-Kozik, Tomasz Wolańczyk, Przemysław Bieńkowski, Dominika Dudek, Janusz Heitzman, Agata Szulc, Jerzy Samochowiec
Psychiatr Pol 2021;55(5):967-987
DOI: https://doi.org/10.12740/PP/140287
 
ARTICLE
 

The position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in the treatment of mental disorders
Adam Wichniak, Jerzy Samochowiec, Agata Szulc, Dominika Dudek, Janusz Heitzman, Małgorzata Janas-Kozik, Tomasz Wolańczyk, Joanna Rymaszewska, Marcin Siwek, Przemysław Bieńkowski
Psychiatr Pol 2021;55(5):941-966
DOI: https://doi.org/10.12740/PP/138177
 
ARTICLE
 

Treatment of insomnia – effect of trazodone and hypnotics on sleep
Adam Wichniak, Aleksandra Ewa Wierzbicka, Marek Jarema
Psychiatr Pol 2021;55(4):743-755
DOI: https://doi.org/10.12740/PP/125650
 
REVIEW
 

False-positive drug test results in patients taking psychotropic drugs. A literature review
Sebastian Masternak, Olga Padała, Hanna Karakuła-Juchnowicz
Psychiatr Pol 2021;55(2):435-446
DOI: https://doi.org/10.12740/PP/113173
 
ARTICLE
 

Treatment-resistant depression - recommendations of the National Consultant in the field of psychiatry
Piotr Gałecki, Katarzyna Bliźniewska-Kowalska
Psychiatr Pol 2021;55(1):7-21
DOI: https://doi.org/10.12740/PP/OnlineFirst/115208
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2020;54(6):1043-1044
DOI: https://doi.org/10.12740/PP/131934
 
LETTER
 

Letter to Editor. Treatment of overweight and obesity during and after a pandemic. Let’s not wait for the development of complications – new guidelines for doctors
Magdalena Olszanecka-Glinianowicz, Dominika Dudek, Krzysztof J Filipiak, Marek Krzystanek, Leszek Markuszewski, Marek Ruchała, Elżbieta Tomiak
Psychiatr Pol 2020;54(6):1263-1268
DOI: https://doi.org/10.12740/PP/130768
 
ARTICLE
 

Lithium treatment – the state of the art for 2020
Janusz Rybakowski
Psychiatr Pol 2020;54(6):1047-1066
DOI: https://doi.org/10.12740/PP/128340
 
LETTER
 

Letter to Editor. Thromboembolic complications in psychiatry from the perspective of legal claims – authors response
Alina Wilkowska, Hanna Kujawska-Danecka, Adam Hajduk
Psychiatr Pol 2020;54(6):1273-1274
DOI: https://doi.org/10.12740/PP/128333
 
ARTICLE
 

A hormetic approach to understanding antidepressant effectiveness and the development of antidepressant tolerance – A conceptual view
Paul Andrews, Jay Amsterdam
Psychiatr Pol 2020;54(6):1067-1090
DOI: https://doi.org/10.12740/PP/120084
 
ARTICLE
 

A half-century of participant observation in psychiatry. Part III: psychopharmacology
Janusz Rybakowski
Psychiatr Pol 2020;54(5):845-864
DOI: https://doi.org/10.12740/PP/126249
 
ARTICLE
 

Amisulpride – is it as all other medicines or is it different? An update
Tomasz Hadryś, Joanna Rymaszewska
Psychiatr Pol 2020;54(5):977-989
DOI: https://doi.org/10.12740/PP/OnlineFirst/109129
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2020;54(4):637-638
DOI: https://doi.org/10.12740/PP/125528
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2020;54(3):401-402
DOI: https://doi.org/10.12740/PP/125527
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2020;54(2):183-184
DOI: https://doi.org/10.12740/PP/119459
 
REVIEW
 

Ayahuasca – potential therapeutic properties in psychiatry. Research review
Aleksandra Barabasz-Gembczyk, Krzysztof Kucia
Psychiatr Pol 2020;54(2):381-389
DOI: https://doi.org/10.12740/PP/103364
 
ARTICLE
 

The role of eugeroics in the treatment of affective disorders
Anna Emilia Urban, Wiesław Jerzy Cubała
Psychiatr Pol 2020;54(1):21-33
DOI: https://doi.org/10.12740/PP/OnlineFirst/90687
 
ARTICLE
 

Epigenetic mechanisms of stress and depression
Natalia Chmielewska, Janusz Szyndler, Piotr Maciejak, Adam Płaźnik
Psychiatr Pol 2019;53(6):1413-1428
DOI: https://doi.org/10.12740/PP/94375
 
ARTICLE
 

The Soteria Project: A forerunner of “a third way” in psychiatry?
Radosław Stupak, Bartłomiej Dobroczyński
Psychiatr Pol 2019;53(6):1351-1364
DOI: https://doi.org/10.12740/PP/OnlineFirst/91731
 
ARTICLE
 

Clozapine-induced myocarditis during co-administration of valproate: A case report
Piotr Jahołkowski, Julita Niewiadomska, Jacek Wciórka, Mirosław Kowalski, Piotr Świtaj
Psychiatr Pol 2019;53(5):997-1002
DOI: https://doi.org/10.12740/PP/105121
 
ARTICLE
 

Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders
Jarosław Woroń, Marcin Siwek, Aleksandra Gorostowicz
Psychiatr Pol 2019;53(5):977-995
DOI: https://doi.org/10.12740/PP/OnlineFirst/96286
 
ARTICLE
 

The evaluation of effect of selected metal ions on the efficiency of passive and active transport of imipramine
Włodzimierz Opoka, Agata Kryczyk, Agata Krakowska, Joanna Piotrowska, Joanna Gdula-Argasińska, Katarzyna Kała, Marlena Linek, Bożena Muszyńska
Psychiatr Pol 2019;53(5):1169-1179
DOI: https://doi.org/10.12740/PP/92301
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2019;53(4):719-720
DOI: https://doi.org/10.12740/PP/111823
 
ARTICLE
 

Treatment of obsessive-compulsive disorders (OCD) and obsessive-compulsive-related disorders (OCRD)
Waldemar Krzyszkowiak, Małgorzata Kuleta-Krzyszkowiak, Eliza Krzanowska
Psychiatr Pol 2019;53(4):825-843
DOI: https://doi.org/10.12740/PP/105130
 
REVIEW
 

Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review
Anna Giménez, Isabella Pacchiarotti, Joaquín Gil, Andrea Murru, Susana P. Gomes, Justo E. Pinzón, Gerard Anmella, Marta Gómez-Ramiro, Norma Verdolini, Marc Valentí, José M. Goikolea, Eduard Vieta
Psychiatr Pol 2019;53(2):223-244
DOI: https://doi.org/10.12740/PP/105906
 
ARTICLE
 

Recommendations of the Polish Psychiatric Association for treatment of affective disorders in women of childbearing age. Part I: Treatment of depression
Jerzy Samochowiec, Janusz Rybakowski, Piotr Galecki, Agata Szulc, Joanna Rymaszewska, Wieslaw Jerzy Cubiała, Dominika Dudek
Psychiatr Pol 2019;53(2):245-262
DOI: https://doi.org/10.12740/PP/103385
 
REVIEW
 

Probiotics supplementation in prophylaxis and treatment of depressive and anxiety disorders – a review of current research
Anna Herman
Psychiatr Pol 2019;53(2):459-473
DOI: https://doi.org/10.12740/PP/92392
 
LETTER
 

Letter to Editor. Thromboembolic complications in psychiatry from the perspective of legal claims
Rafał Skowronek, Marek Krzystanek, Jerzy Chudek
Psychiatr Pol 2019;53(1):209-211
DOI: https://doi.org/10.12740/PP/99145
 
REVIEW
 

The Occurrence of Postoperative Cognitive Dysfunction (POCD) – Systematic Review
Katarzyna Czyż-Szypenbejl, Wioletta Mędrzycka-Dąbrowska, Katarzyna Kwiecień-Jaguś, Katarzyna Lewandowska
Psychiatr Pol 2019;53(1):145-160
DOI: https://doi.org/10.12740/PP/90648
 
ARTICLE
 

Increase in pharmacodynamic tolerance after repeated antidepressant trials in treatment-responsive bipolar I depressed subjects: An exploratory study
Jay D. Amsterdam, Lorenzo Lorenzo-Luaces
Psychiatr Pol 2018;52(6):957-969
DOI: https://doi.org/10.12740/PP/98961
 
ARTICLE
 

Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts.
Jarosław Woroń, Marcin Siwek
Psychiatr Pol 2018;52(6):983-996
DOI: https://doi.org/10.12740/PP/OnlineFirst/80998
 
ARTICLE
 

Cariprazine – a novel antipsychotic drug and its place in the treatment of schizophrenia
Błażej Misiak, Przemysław Bieńkowski, Jerzy Samochowiec
Psychiatr Pol 2018;52(6):971-981
DOI: https://doi.org/10.12740/PP/OnlineFirst/80710
 
ARTICLE
 

Effects of atorvastatin on treatment-resistant obsessive-compulsive disorder: A double-blind randomized trial
Fakher Rahim, Mehdi Sayyah
Psychiatr Pol 2018;52(4):719-729
DOI: https://doi.org/10.12740/PP/OnlineFirst/69422
 
ARTICLE
 

Dopaminergic system activity under stress condition – seeking individual differences, preclinical studies
Marek Gryz, Małgorzata Lehner, Aleksandra Wisłowska-Stanek, Adam Płaźnik
Psychiatr Pol 2018;52(3):459-470
DOI: https://doi.org/10.12740/PP/80500
 
REVIEW
 

Risk and prophylaxis of venous thromboembolism in hospitalized psychiatric patients. A review
Alina Wilkowska, Hanna Kujawska-Danecka, Adam Hajduk
Psychiatr Pol 2018;52(3):421-435
DOI: https://doi.org/10.12740/PP/78891
 
ARTICLE
 

Industry-corrupted psychiatric trials
Jay D. Amsterdam, Leemon B. McHenry, Jon N. Jureidini
Psychiatr Pol 2017;51(6):993-1008
DOI: https://doi.org/10.12740/PP/80136
 
ARTICLE
 

Venlafaxine and sertraline does not affect the expression of genes regulating stress response in female MDD patients
Ewa Banach, Aleksandra Szczepankiewicz, Anna Leszczyńska-Rodziewicz, Joanna Pawlak, Monika Dmitrzak-Węglarz, Dorota Zaremba, Joanna Twarowska-Hauser
Psychiatr Pol 2017;51(6):1029-1038
DOI: https://doi.org/10.12740/PP/76329
 
ARTICLE
 

Comparison of the effect of intravenous anesthetics used for anesthesia during electroconvulsive therapy on the hemodynamic safety and the course of ECT
Rafał Wojdacz, Łukasz Święcicki, Anna Antosik-Wójcińska
Psychiatr Pol 2017;51(6):1039-1058
DOI: https://doi.org/10.12740/PP/75635
 
ARTICLE
 

A retrospective study of DRESS – drug reaction with eosinophilia and systemic symptoms
Dorota Mehrholz, Anna Emilia Urban, Marta Herstowska, Roman Nowicki, Wiesław Cubała, Wioletta Barańska-Rybak
Psychiatr Pol 2017;51(6):1079-1093
DOI: https://doi.org/10.12740/PP/74358
 
ARTICLE
 

Therapeutic drug monitoring of atypical antipsychotics.
Anna Emilia Urban, Wiesław Jerzy Cubała
Psychiatr Pol 2017;51(6):1059-1077
DOI: https://doi.org/10.12740/PP/65307
 
EDITORIAL MATERIAL
 

Conference report. The 13th World Congress of Biological Psychiatry, Copenhagen, Denmark 18-22.06.2017
Anna Zofia Antosik-Wójcińska
Psychiatr Pol 2017;51(5):981-982
DOI: https://doi.org/10.12740/PP/76629
 
ARTICLE
 

Treatment guidelines for Circadian Rhythm Sleep – Wake Disorders of the Polish Sleep Research Society and the Section of Biological Psychiatry of the Polish Psychiatric Association. Part II. Diagnosis and treatment
Adam Wichniak, Konrad S. Jankowski, Michał Skalski, Krystyna Skwarło-Sońta, Jolanta B. Zawilska, Marcin Żarowski, Ewa Poradowska, Wojciech Jernajczyk
Psychiatr Pol 2017;51(5):815-832
DOI: https://doi.org/10.12740/PP/68918
 
ARTICLE
 

Vulvodynia and depression – a case study
Aneta Gerhant, Ewelina Anna Dziwota, Aneta Perzyńska-Starkiewicz, Magdalena Derewianka-Polak, Marcin Olajossy
Psychiatr Pol 2017;51(5):937-952
DOI: https://doi.org/10.12740/PP/67371
 
ARTICLE
 

Treatment guidelines for Circadian Rhythm Sleep-Wake Disorders of the Polish Sleep Research Society and the Section of Biological Psychiatry of the Polish Psychiatric Association. Part I. Physiology, assessment and therapeutic methods
Adam Wichniak, Konrad S. Jankowski, Michal Skalski, Krystyna Skwarło-Sońta, Jolanta B. Zawilska, Marcin Żarowski, Ewa Poradowska, Wojciech Jernajczyk
Psychiatr Pol 2017;51(5):793-814
DOI: https://doi.org/10.12740/PP/OnlineFirst/66810
 
ARTICLE
 

The effect of vitamin D3 deficiency on the severity of depressive symptoms. Overview of current research.
Bogdan Stefanowski, Anna Zofia Antosik-Wójcińska, Łukasz Święcicki
Psychiatr Pol 2017;51(3):437-454
DOI: https://doi.org/10.12740/PP/66809
 
ARTICLE
 

The serum concentration of copper in bipolar disorder
Marcin Siwek, Krzysztof Styczeń, Magdalena Sowa-Kućma, Dominika Dudek, Witold Reczyński, Bernadeta Szewczyk, Paulina Misztak, Włodzimierz Opoka, Roman Topór-Mądry, Gabriel Nowak, Janusz K. Rybakowski
Psychiatr Pol 2017;51(3):469-481
DOI: https://doi.org/10.12740/PP/OnlineFirst/65250
 
ARTICLE
 

Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy
Marcin Olajossy, Bartosz Olajossy, Sebastian Wnuk, Emilia Potembska, Ewa Urbańska
Psychiatr Pol 2017;51(3):455-468
DOI: https://doi.org/10.12740/PP/61584
 
ARTICLE
 

Genetics and pharmacogenetics of mood disorders
Alessandro Serretti
Psychiatr Pol 2017;51(2):197-203
DOI: https://doi.org/10.12740/PP/68914
 
ARTICLE
 

Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia
Marek Jarema, Przemysław Bieńkowski, Janusz Heitzman, Tadeusz Parnowski, Janusz Rybakowski
Psychiatr Pol 2017;51(1):7-21
DOI: https://doi.org/10.12740/PP/64581
 
ARTICLE
 

Psychotic symptoms as a complication of electroconvulsive therapy – a case report
Anna Antosik-Wójcińska, Magdalena Chojnacka, Łukasz Święcicki
Psychiatr Pol 2017;51(1):23-27
DOI: https://doi.org/10.12740/PP/62983
 
ARTICLE
 

Othello syndrome after STN DBS – psychiatric side-effects of DBS and methods of dealing with them
Anna Zofia Antosik-Wójcińska, Łukasz Święcicki, Przemysław Bieńkowski, Tomasz Mandat, Emilia Sołtan
Psychiatr Pol 2016;50(2):323-327
DOI: https://doi.org/10.12740/PP/34042
 
ARTICLE
 

Psychiatric disturbances as a first clinical symptom of Wilson’s disease – case report.
Tomasz Litwin, Karolina Dzieżyc, Michał Karliński, Tomasz Szafrański, Anna Członkowska
Psychiatr Pol 2016;50(2):337-344
DOI: https://doi.org/10.12740/PP/45218
 

Relationship between diabetic neuropathy and occurrence of depression among diabetic patients
Piotr Dziemidok, Mariusz Dąbrowski, Marta Makara-Studzińska
Psychiatr Pol 2016;50(2):407-415
DOI: https://doi.org/10.12740/PP/OnlineFirst/42352
 
ARTICLE
 

Effects of statins on delirium following cardiac surgery – evidence from literature
Giovanni Mariscalco, Silvia Mariani, Fausto Biancari, Maciej Banach
Psychiatr Pol 2015;49(6):1359-1370
DOI: https://doi.org/10.12740/PP/60139
 
ARTICLE
 

Efficacy and safety of antidepressant’s use in the treatment of depressive episodes in bipolar disorder – review of research
Anna Zofia Antosik-Wójcińska, Bogdan Stefanowski, Łukasz Święcicki
Psychiatr Pol 2015;49(6):1223-1239
DOI: https://doi.org/10.12740/PP/37914
 
ARTICLE
 

BDNF as a biomarker in the course and treatment of schizophrenia
Małgorzata Libman-Sokołowska, Ewa Drozdowicz, Tadeusz Nasierowski
Psychiatr Pol 2015;49(6):1149-1158
DOI: https://doi.org/10.12740/PP/37705
 
ARTICLE
 

The use of ketamine in electroconvulsive therapy
Krzysztof Kucia, Wojciech Merk
Psychiatr Pol 2015;49(6):1255-1263
DOI: https://doi.org/10.12740/PP/31748
 
ARTICLE
 

Combined use of ECT and psychotropic drugs
Wojciech Merk, Krzysztof Kucia
Psychiatr Pol 2015;49(6):1241-1253
DOI: https://doi.org/10.12740/PP/37462
 
ARTICLE
 

The serum concentration of magnesium as a potential state marker in patients with diagnosis of bipolar disorder
Marcin Siwek, Krzysztof Styczeń, Magdalena Sowa-Kućma, Dominika Dudek, Witold Reczyński, Bernadeta Szewczyk, Paulina Misztak, Włodzimierz Opoka, Roman Topór-Mądry, Gabriel Nowak
Psychiatr Pol 2015;49(6):1277-1287
DOI: https://doi.org/10.12740/PP/OnlineFirst/42047
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2015;49(5):879-881
DOI: https://doi.org/10.12740/PP/59546
 
LETTER
 

Letter to Editor. Use of specific SSRIs and birth defects
Ewa Bałkowiec-Iskra
Psychiatr Pol 2015;49(5):1113-1116
DOI: https://doi.org/10.12740/PP/59304
 

Conference report: Progress in Biomedicine & Neuromedicine. Workshop with Nobel Prize Winner Professor Erwin Neher), Kraków 21–23.06.2015 r.
Sławomir Murawiec, Adrian Andrzej Chrobak
Psychiatr Pol 2015;49(4):865-870
DOI: https://doi.org/10.12740/PP/58870
 

Acute psychosis in the course of treatment of acute adrenal crisis with hydrocortisone in the patient with secondary adrenal insufficiency – a case study.
Jan Brykalski, Lucyna Papierska, Maria Załuska
Psychiatr Pol 2015;49(4):673-681
DOI: https://doi.org/10.12740/PP/28342
 
ARTICLE
 

Natural products of relevance in the prevention and supportive treatment of depression
Bożena Muszyńska, Maciej Łojewski, Jacek Rojowski, Włodzimierz Opoka, Katarzyna Sułkowska-Ziaja
Psychiatr Pol 2015;49(3):435-453
DOI: https://doi.org/10.12740/PP/29367
 
ARTICLE
 

Guidelines for the use of second-generation long-acting antipsychotics
Marek Jarema, Adam Wichniak, Dominika Dudek, Jerzy Samochowiec, Przemysław Bieńkowski, Janusz Rybakowski
Psychiatr Pol 2015;49(2):225-241
DOI: https://doi.org/10.12740/PP/39370
 
ARTICLE
 

GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators
Roberta Agabio, Giancarlo Colombo
Psychiatr Pol 2015;49(2):215-223
DOI: https://doi.org/10.12740/PP/33911
 
EDITORIAL MATERIAL
 

Editorial
Dominika Dudek, Jerzy A. Sobański, Katarzyna Klasa
Psychiatr Pol 2015;49(2):211-212
DOI: https://doi.org/10.12740/PP/42177
 
ARTICLE
 

The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patients with schizophrenia treated with olanzapine - a randomized, double-blind trial.
Justyna Anna Holka-Pokorska, Rafał Radzio, Marek Jarema, Adam Wichniak
Psychiatr Pol 2015;49(2):363-376
DOI: https://doi.org/10.12740/PP/30180
 
ARTICLE
 

Comorbidity of alcohol dependence with other psychiatric disorders. Part II. Pathogenesis and treatment
Anna Klimkiewicz, Jakub Klimkiewicz, Andrzej Jakubczyk, Ilona Kieres-Salomoński, Marcin Wojnar
Psychiatr Pol 2015;49(2):277-294
DOI: https://doi.org/10.12740/PP/26071
 
ARTICLE
 

Towards better non-selectivity: the role of 5-HT7 receptors in therapeutic efficacy of a second-generation antipsychotic, lurasidone
Przemysław Bieńkowski, Dominika Dudek, Jerzy Samochowiec
Psychiatr Pol 2015;49(2):243-253
DOI: https://doi.org/10.12740/PP/38250
 

The place of quetiapine extended release in the treatment of mental disorders
Krzysztof Styczeń, Wojciech Datka, Rafał Jaeschke, Katarzyna Drozdowicz, Marcin Siwek, Dominika Dudek
Psychiatr Pol 2015;49(1):67-80
DOI: https://doi.org/10.12740/PP/33909
 

Cognitive dysfunctions in depression – underestimated symptom or new dimension?
Marek Jarema, Dominika Dudek, Andrzej Czernikiewicz
Psychiatr Pol 2014;48(6):1105-1116
DOI: https://doi.org/10.12740/PP/31215
 

Staging of unipolar affective illness
Ewa Ferensztajn, Agnieszka Remlinger-Molenda, Janusz Rybakowski
Psychiatr Pol 2014;48(6):1127-1141
DOI: https://doi.org/10.12740/PP/24239
 

Tardive dyskinesia in patients with schizophrenia treated with olanzapine – results from a 20-month, prospective, open study under naturalistic conditions
Tomasz Szafrański
Psychiatr Pol 2014;48(6):1155-1165
DOI: https://doi.org/10.12740/PP/23981
 

New prospects for antipsychotic treatment - the role of the kynurenine pathway
Hanna Karakuła-Juchnowicz, Marta Flis, Kinga Szymona, Maryla Kuczyńska, Ewa Stelmach, Agnieszka Kowal-Popczak
Psychiatr Pol 2014;48(6):1167-1177
DOI: https://doi.org/10.12740/PP/25520
 

Inhaled loxapine: A novel treatment for agitation in psychotic disorders
Marcin Siwek
Psychiatr Pol 2014;48(5):917-930
DOI: https://doi.org/10.12740/PP/30255
 

Venous thromboembolism as an adverse effect of antipsychotic treatment
Ewa Bałkowiec-Iskra, Grzegorz Cessak, Łucja Kryńska, Bartosz Łoza, Marcin Wojnar
Psychiatr Pol 2014;48(5):997-1014
DOI: https://doi.org/10.12740/PP/23018
 

„Mid-stimulation psychosis” in the course of in vitro fertilization procedure with the use of clomiphene citrate and bromocriptine – case study
Justyna Holka-Pokorska, Agnieszka Piróg-Balcerzak, Artur Stefanowicz
Psychiatr Pol 2014;48(5):901-916
DOI: https://doi.org/10.12740/PP/24434
 

Mood stabilisers and pregnancy outcomes - a review
Giulia Costoloni, Elisa Pierantozzi, Arianna Goracci, Simone Bolognesi, Andrea Fagiolini
Psychiatr Pol 2014;48(5):865-887
DOI: https://doi.org/10.12740/PP/25834
 

Sexual Dysfunctions, Psychiatric Diseases and Quality of Life: A Review.
Letizia Bossini, Valentina Fortini, Casolaro Ilaria, Claudia Caterini, Despoina Koukouna, Federica Cecchini, Jim Benbow, Andrea Fagiolini
Psychiatr Pol 2014;48(4):715-726
 

Różnice w treści ulotek leków zawierających zolpidem
Iga Joanna Pawłowska, Leszek Pawłowski, Ivan Kocić
Psychiatr Pol 2014;48(4):850-853
 

Herbal remedies in depression – state of the art.
Tomasz Szafrański
Psychiatr Pol 2014;48(1):59-73
DOI: https://doi.org/10.12740/PP/21865
 

Factors connected with efficacy of single ketamine infusion in bipolar depression
Agnieszka Permoda-Osip, Maria Skibińska, Alicja Bartkowska-Śniatkowska, Sebastian Kliwicki, Maria Chłopocka-Woźniak, Janusz K. Rybakowski
Psychiatr Pol 2014;48(1):35-47
DOI: https://doi.org/10.12740/PP/21175
 

Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy.
Paweł Gosek, Magdalena Chojnacka, Łukasz Święcicki, Przemysław Bieńkowski
Psychiatr Pol 2014;48(1):49-58
DOI: https://doi.org/10.12740/PP/20566
 

Oxytocin model of formation of psychotic symptoms and its implication for research concerning oxytocinergic pathway in schizophrenia
Justyna Anna Holka-Pokorska, Marek Jarema
Psychiatr Pol 2014;48(1):19-33
DOI: https://doi.org/10.12740/PP/18377
 

Bourning mouth syndrome: pathogenic and therapeutic concepts.
Ewa Ferensztajn, Dorota Łojko, Janusz Rybakowski
Psychiatr Pol 2013;47(6):973-988
DOI: https://doi.org/10.12740/PP/19617
 

Four measures of treatment compliance among patients recovering from psychotic episodes – a comparative study
Jacek Wciórka, Karolina Friemann
Psychiatr Pol 2013;47(5):759-773
DOI: https://doi.org/10.12740/PP/18341
 

The influence of antipsychotic therapy on the cognitive functions of schizophrenic patients
Piotr Tybura, Monika Mak, Agnieszka Samochowiec, Justyna Pełka Wysiecka, Anna Grzywacz, Elżbieta Grochans, Liliana Zareba-Pechmann, Jerzy Samochowiec
Psychiatr Pol 2013;47(4):567-576
DOI: https://doi.org/10.12740/PP/17946
 
Most read
Indexes
 
Keywords index
Topics index
Authors index
eISSN:2391-5854
ISSN:0033-2674
Journals System - logo
The journal is supported by the State Treasury as part of the Development of Scientific Journals (RCN) program
Project no. RCN/SN/0610/2021/1 implemented from 2022 to 2024
Total value of the project: PLN 490 000
Amount funded by the MEiN: PLN 100 000
Aims of the project: Publication in Open Access mode on the Internet of English and Polish language versions of 12 consecutive issues of the journal Psychiatria Polska (years 2022-2024). Modernization and redesign of the journal’s website. Financing of the Editorial System. Copy editing and proofreading of journal issues. Counteracting scientific misinformation. Submission of electronic versions of the journal to the National Digital Library Polona and the Digital Library of Scientific Publications Academica.
© 2006-2024 Journal hosting platform by Bentus
Scroll to top